A1C Almanac

Main Page

When Fragmented Sleep Makes the Heart Forget to Rest

Posted

by

dr Karunia Valeriani Japar

Table of Contents
Category:
Tags: , , , , ,

Keywords: Sleep Fragmentation, Cardiometabolic Resilience, Circadian Disruption, Sympathetic Overactivity, Metabolic Aging

The Paradox of the Modern of the Modern Heart

Sleep deprivation has emerged as an underrecognized but pervasive determinant of cardiovascular health in contemporary society. The pursuit of productivity and performance has led to an unprecedented prevalence of chronic sleep restriction, often regarded as a badge of efficiency rather than a biological stressor. Among health-conscious individuals, substantial attention is given to exercise, blood pressure control, and dietary supplementation; yet the restorative function of sleep, particularly its continuity, remains neglected. Fragmented sleep, even in the absence of total deprivation, disrupts the complex neuroendocrine and metabolic processes that sustain cardiovascular resilience and systemic repair.

Growing evidence indicates that disturbed sleep architecture promotes cardiometabolic dysfunction through multiple converging pathways, including impaired glucose regulation, heightened oxidative stress, and sympathetic overactivation (Covassin & Singh, 2016; St-Onge et al., 2016). Epidemiological studies have consistently shown that individuals with irregular or shortened sleep exhibit higher risks of hypertension, insulin resistance, and coronary artery disease, independent of traditional risk factors (Cappuccio et al., 2011; Javaheri et al., 2017). Mechanistically, repetitive sleep fragmentation interferes with the molecular clocks that govern circadian cardiac rhythms, resulting in misalignment between physiological rest-activity cycles and internal metabolic signalling (Scheer et al., 2009). As a result, the heart,  rhythmic organ synchronized to circadian and autonomic cues becomes susceptible to maladaptive remodelling, vascular inflammation, and accelerated biological aging.

The Heart’s Circadian Code

The cardiovascular system is tightly regulated by intrinsic circadian clocks that operate at both central and peripheral levels. Experimental work has demonstrated that cardiomyocytes and vascular cells express a functional transcription–translation feedback loop involving CLOCK, BMAL1, PER, and CRY, which coordinates daily oscillations in cardiac metabolism, contractility, and electrophysiology independently of the suprachiasmatic nucleus (SCN). Disruption of these peripheral cardiac clocks in animal models, such as cardiomyocyte-specific deletion of Bmal1 or Clock, leads to impaired myocardial relaxation, mitochondrial dysfunction, and increased vulnerability to ischemic injury, highlighting the importance of circadian integrity for cardiac resilience. At the systems level, human studies show that blood pressure, heart rate, vascular tone, and coagulation exhibit robust diurnal variation, with a characteristic morning surge coinciding with heightened sympathetic activity and a transient prothrombotic state [1,2].

Figure 1. Multiorgan distribution of peripheral circadian clocks and their physiological functions [1]

Sleep serves as a primary synchronizing cue for these cardiovascular rhythms, facilitating nocturnal declines in blood pressure, increases in heart rate variability (HRV), and endothelial repair. Meta-analytic data indicate that sleep deprivation reduces parasympathetic activity, reflected by decreased RMSSD and increased LF/HF ratio, signalling a shift toward sympathetic dominance and impaired autonomic balance. Controlled human experiments further suggest that inadequate or fragmented sleep is associated with reduced HRV and trends toward impaired flow-mediated dilation, implying compromised endothelial function and reduced vascular adaptability, particularly in shift workers who experience circadian disruption. Mechanistically, this autonomic imbalance and endothelial stress provide a plausible pathway linking disturbed sleep with early cardiovascular injury [3-5].

When sleep is chronically restricted or fragmented, due to psychosocial stress, late-evening light exposure, or shift work, temporal signalling that governs lipid handling, glucose utilization, and inflammatory responses becomes misaligned with behavioural cycles. Circadian desynchrony between the SCN and peripheral clocks in metabolic and cardiovascular tissues has been proposed as a central mechanism in the development of cardiometabolic syndrome, with altered rhythmic expression of genes such as pdk4 and ucp3 in the heart contributing to impaired substrate flexibility and energy efficiency. In this context, even in the absence of overt sleep apnea or insomnia, repeated sleep fragmentation may gradually erode the heart’s capacity for nighttime repair, thereby advancing subclinical cardiovascular aging [2,6,7]. 

Epidemiological and experimental data underscore the inflammatory dimension of this process. Large cohort analyses have shown that short sleep duration is associated with higher levels of C-reactive protein (CRP) and increased long-term cardiovascular mortality, with a nadir of risk typically observed around 6–7 hours of sleep per night. Laboratory studies complement these findings, demonstrating that partial sleep restriction can acutely elevate CRP and interleukin-6 (IL-6), creating a low-grade proinflammatory milieu that is closely linked to endothelial dysfunction and atherosclerotic progression. Together, these observations support the concept that insufficient or fragmented sleep disrupts the circadian regulation of autonomic, metabolic, and inflammatory pathways, thereby undermining vascular health and accelerating atherogenesis [8,9,10]. 

Broken Sleep and Metabolic Chaos

A growing body of experimental and epidemiologic evidence supports a bidirectional relationship between sleep disruption and metabolic dysregulation. Short-term sleep restriction in healthy adults, even over the course of a single week, has been shown to significantly reduce whole-body insulin sensitivity without altering insulin secretion, indicating a primary defect in insulin action at the tissue level. In one controlled trial, restricting time in bed to 5 hours per night for 7 consecutive nights led to an 11–20% reduction in insulin sensitivity as assessed by both intravenous glucose tolerance testing and euglycemic–hyperinsulinemic clamp, raising concern that habitual insufficient sleep may contribute to the development of insulin-resistant states in otherwise low-risk individuals. Complementary work in both healthy volunteers and individuals with existing metabolic risk suggests that sleep fragmentation, independent of total sleep duration, can impair glucose tolerance by reducing insulin-mediated peripheral glucose uptake and enhancing hepatic glucose output [11,12,13]. 

Mechanistically, disturbed sleep appears to alter glucose homeostasis via activation of the hypothalamic–pituitary–adrenal (HPA) axis and the sympathetic nervous system. Experimental sleep fragmentation across multiple nights has been associated with a 20–25% reduction in indices of insulin sensitivity, a shift in sympathovagal balance toward sympathetic dominance, and a significant rise in morning cortisol levels. Elevated nocturnal and early-morning cortisol, even within the physiologic range, promotes hepatic gluconeogenesis and reduces insulin-mediated glucose disposal, thereby favouring nocturnal and early-day hyperglycemia. These hormonal and autonomic changes create a metabolic milieu characterized by higher fasting glucose, impaired postprandial control, and increased free fatty acid flux patterns that have been repeatedly linked to increased risk of type 2 diabetes and metabolic syndrome in population studies. From a clinical perspective, this constellation of alterations suggests that fragmented sleep functions as a chronic, low-grade stressor that accelerates the transition from normometabolism to insulin resistance and cardiometabolic disease [12,13,14,15,16].

From the standpoint of aging biology, chronic sleep disruption may act as a driver of “metabolic aging,” reflecting a progressive decline in cellular bioenergetic capacity. Preclinical studies demonstrate that sleep loss and sleep fragmentation can impair mitochondrial oxidative phosphorylation, increase reactive oxygen species production, and alter the balance of mitochondrial fusion and fission, ultimately reducing ATP-generating efficiency. Emerging human data suggest that poor sleep efficiency and short sleep duration are associated with compromised systemic mitochondrial bioenergetics, including reduced activity of electron transport chain complexes and increased oxidative stress. This bioenergetic deficit is clinically relevant because impaired mitochondrial function in vascular and cardiac tissues has been implicated in arterial stiffening, reduced endothelial nitric oxide availability, and elevated resting heart rate, early markers of cardiometabolic strain and vascular aging. In this context, broken sleep can be conceptualized not merely as a symptom of modern lifestyles but as a modifiable accelerator of cardiometabolic aging acting through intertwined endocrine, autonomic, and mitochondrial pathways [14,16,17,18].

The Hidden Sympathetic Load

Sleep fragmentation is characterized by recurrent “micro-arousals,” brief intrusions of wake-like activity into sleep that amplify activation of both the hypothalamic–pituitary–adrenal (HPA) axis and the sympathetic nervous system (SNS). These repeated arousals have been associated with increased secretion of cortisol, epinephrine, and norepinephrine, alongside elevations in heart rate and blood pressure, indicating a state of chronic sympathoexcitation. Experimental and clinical data suggest a bidirectional relationship in which heightened HPA activity and stress responsivity promote sleep fragmentation, while fragmented sleep further stimulates HPA axis activity, thereby perpetuating a cycle of hyperarousal. In this context, alterations in heart rate variability (HRV) with reduced parasympathetic indices and relative increases in sympathetic markers, serve as indirect evidence of a sustained shift toward sympathetic dominance even during periods that should be physiologically restorative [19,20,21,22].

One of the key hemodynamic consequences of this hidden sympathetic load is the disruption of normal nocturnal blood pressure dipping. Under physiological conditions, blood pressure falls by approximately 10–20% during sleep, reflecting reduced sympathetic tone and enhanced parasympathetic activity; in “non-dipping” patterns, this decline is blunted or absent, often in the setting of poor sleep quality or insomnia. Observational studies and ambulatory blood pressure monitoring cohorts have consistently shown that non-dipping blood pressure and heart rate patterns are associated with increased risks of stroke, heart failure, and composite cardiovascular events, even after adjustment for traditional risk factors. Long-term follow-up data indicate that individuals with persistently non-dipping blood pressure trajectories have a markedly higher incidence of non-fatal cardiovascular events compared with those who maintain a dipping pattern, supporting the notion that nocturnal hemodynamics convey prognostic information beyond office blood pressure alone [23,24,25,26]. 

Over time, the cardiovascular system may interpret this pattern of nocturnal sympathoexcitation and non-dipping hemodynamics as a signal of ongoing threat, triggering structural and functional remodelling. Chronic sympathetic overactivity and loss of nocturnal blood pressure decline contribute to increased arterial stiffness, endothelial dysfunction, and left ventricular hypertrophy, thereby compromising diastolic filling and promoting subclinical heart failure phenotypes. These maladaptive changes appear to translate into elevated cardiovascular morbidity and mortality that cannot be fully explained by daytime blood pressure, cholesterol, or other conventional risk markers, highlighting sleep and autonomic regulation as independent axes of cardiovascular risk. From a mechanistic standpoint, the hidden sympathetic burden imposed by fragmented sleep thus represents a critical, yet often overlooked, pathway through which disrupted sleep architecture accelerates vascular aging and cardiac vulnerability [20,23,25,26,].

Restoring Sleep as Cardiac Therapy

Emerging work at the intersection of sleep medicine, circadian biology, and cardiometabolic prevention supports the concept of sleep as a modifiable therapeutic target for cardiovascular health. Interventions that stabilize circadian timing, such as maintaining consistent bed and wake times, prioritizing morning light exposure, and minimizing light exposure in the late evening have been associated with improved metabolic profiles, lower blood pressure, and reduced cardiometabolic risk. Experimental data demonstrate that even a single night of moderate light exposure during sleep can increase nocturnal heart rate, reduce heart rate variability, and impair next-morning insulin sensitivity in healthy adults, underscoring the importance of a dark sleep environment for autonomic and metabolic homeostasis. Observational studies further suggest that habitual light at night and circadian disruption may increase incident cardiovascular disease, possibly via misalignment of central and peripheral clocks and suppression of nocturnal melatonin [14,27,28,29,30,31].

In parallel, mind–body and autonomic-focused interventions are gaining attention as adjunctive strategies to reduce sleep fragmentation and support cardiovascular resilience. Preliminary randomized data indicate that yoga nidra is a feasible and well-tolerated intervention for adults with insomnia, with early evidence of beneficial effects on respiratory rate and subjective sleep quality, and emerging work (including unpublished and small trials) suggesting potential improvements in heart rate variability when combined with other yoga practices. Controlled breathing exercises and structured breathwork have been shown to enhance parasympathetic activity, lower sympathetic arousal, and reduce blood pressure and cortisol, thereby promoting a physiological state conducive to sleep onset and maintenance. These autonomic shifts, reflected in improved HRV patterns, align mechanistically with reduced nocturnal “sympathetic load,” offering a plausible route by which mind–body interventions may indirectly protect vascular function and cardiometabolic health [32,33].

The rapid adoption of consumer wearable devices has created new opportunities to monitor the “sleep–heart–metabolism” axis in free-living conditions. Continuous tracking of heart rate, HRV, sleep stages, and in some cases nocturnal glucose, can reveal dynamic autonomic signatures associated with glycemic status and cardiometabolic risk. Recent analyses show that overnight trends in HR and HRV derived from wrist-worn devices distinguish individuals with lower versus higher glycemic risk more robustly than static mean values, suggesting that nocturnal autonomic stability is tightly coupled to metabolic health. These findings support the feasibility of using sleep-derived digital biomarkers to guide personalized preventive interventions, shifting emphasis from reactive management of established disease to proactive optimization of sleep and autonomic balance in at-risk individuals [14,34].

Clinical programs focused on cardiometabolic prevention increasingly incorporate structured sleep optimization as a core component rather than a secondary lifestyle recommendation. Treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) has been shown to improve endothelial function, as measured by brachial artery flow-mediated dilation, and to reduce circulating C-reactive protein levels, indicating attenuation of vascular inflammation and potential reduction of cardiovascular risk. Similarly, cognitive behavioral therapy for insomnia (CBT-I) has been associated with improvements in glycemic control (HbA1c) and reductions in CRP in several studies, suggesting that addressing insomnia can favourably influence both inflammatory tone and glucose regulation. Together, these data support conceptualizing sleep not solely as a symptom domain but as an upstream therapeutic lever capable of modulating autonomic balance, inflammatory pathways, insulin signalling, and endothelial repair, a fundamental process required for a long-lived, metabolically stable heart [14,31,34,35].

Longevity Begins in the Dark

Across experimental, epidemiologic, and clinical data, sleep emerges as a central determinant of cardiometabolic resilience rather than a passive state of rest. A healthy heart is not shaped by diet and physical activity alone, but is continuously restored during the nocturnal window in which autonomic balance shifts toward parasympathetic dominance, hormonal rhythms are recalibrated, and cellular repair processes, including endothelial recovery, mitochondrial maintenance, and inflammatory resolution are preferentially engaged. In this context, sleep should be understood as an active, time-structured form of cardiometabolic therapy, integral to preserving vascular integrity and delaying the onset of metabolic disease.

Accordingly, the concept of prevention in cardiovascular and metabolic medicine must evolve to include systematic assessment and optimization of sleep continuity, duration, and circadian alignment as core therapeutic targets rather than ancillary lifestyle factors. Viewing sleep as “medicine” implies that stabilizing circadian timing, protecting the dark phase from light and autonomic intrusion, and treating sleep disorders such as insomnia or sleep apnea can modulate autonomic tone, insulin sensitivity, and vascular inflammation in ways comparable to, and potentially synergistic with, pharmacologic interventions. In the era of data-driven longevity, characterized by continuous monitoring of heart rate variability, sleep architecture, and nocturnal hemodynamics, deep, consolidated, and restorative sleep may represent one of the most underutilized yet powerful levers for slowing cardiovascular aging and extending health span.

Reference

  1. Bautista J, Sofía Ojeda-Mosquera, Ordóñez-Lozada D, Andrés López-Cortés. Peripheral clocks and systemic zeitgeber interactions: from molecular mechanisms to circadian precision medicine. Frontiers in Endocrinology [Internet]. 2025 May 29;16. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12158691/
  2. Young ME, Bray MS. Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Medicine. 2007 Sep;8(6):656–67.
  3. Zhang S, Niu X, Ma J, Wei X, Zhang J, Du W. Effects of sleep deprivation on heart rate variability: a systematic review and meta-analysis. Frontiers in neurology [Internet]. 2025 Summer;16:1556784. Available from: https://pubmed.ncbi.nlm.nih.gov/40895095/
  4. Wehrens SM, Hampton SM, Skene DJ. Heart rate variability and endothelial function after sleep deprivation and recovery sleep among male shift and non-shift workers. Scandinavian Journal of Work, Environment & Health. 2011 Sep 27;38(2):171–81.
  5. Holmer BJ, Lapierre SS, Jake-Schoffman DE, Christou DD. Effects of sleep deprivation on endothelial function in adult humans: a systematic review. GeroScience. 2021 Feb 9;
  6. Zhang S, Dai M, Wang X, Jiang SH, Hu LP, Zhang XL, et al. Signalling entrains the peripheral circadian clock. Cellular Signalling [Internet]. 2020 May 1;69:109433. Available from: https://www.sciencedirect.com/science/article/pii/S0898656819302293
  7. Hunter AL, Bechtold DA. The metabolic significance of peripheral tissue clocks. Communications Biology [Internet]. 2025 Mar 26;8(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11947457/
  8. Grandner M, Sands-Lincoln, Pak, Garland. Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nature and Science of Sleep [Internet]. 2013 Jul;93. Available from: https://www.dovepress.com/sleep-duration-cardiovascular-disease-and-proinflammatory-biomarkers-peer-reviewed-article-NSS
  9. Singh, A. Effects of Inadequate Sleep on Cardiovascular Parameters: A Randomized Crossover Study. European Journal of Cardiovascular Medicine [Internet]. 2025 Sep 22;15:608–11. Available from: https://www.healthcare-bulletin.co.uk/article/effects-of-inadequate-sleep-on-cardiovascular-parameters-a-randomized-crossover-study-4245/
  10. Gupta K, Nagalli S, Kalra R, Gupta R, Mahmood S, Jain V, et al. Sleep duration, baseline cardiovascular risk, inflammation and incident cardiovascular mortality in ambulatory U.S. Adults: National health and nutrition examination survey. American Journal of Preventive Cardiology. 2021 Dec;8:100246.
  11. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men. Diabetes. 2010 Jun 28;59(9):2126–33.
  12. Stamatakis KA, Punjabi NM. Effects of Sleep Fragmentation on Glucose Metabolism in Normal Subjects. Chest [Internet]. 2010 Jan;137(1):95–101. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803120/
  13. Briançon-Marjollet A, Weiszenstein M, Henri M, Thomas A, Godin-Ribuot D, Polak J. The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetology & Metabolic Syndrome [Internet]. 2015 Mar 24;7(1). Available from: https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0018-3
  14. Knutson KL. Sleep duration and cardiometabolic risk: A review of the epidemiologic evidence. Best Practice & Research Clinical Endocrinology & Metabolism. 2010 Oct;24(5):731–43.
  15. Amgad Elshoeibi, Aishat Akomolafe, Al-Khulaifi A, Metwally O, Roudah Al-Khayarin, Rahman A, et al. The Association Between Short Sleep Duration and Metabolic Syndrome: A Case-Control Study. Diabetes Metabolic Syndrome and Obesity. 2023 Dec 1;Volume 16:4157–67.
  16. Dejenie TA, G/Medhin MT, Admasu FT, Adella GA, Enyew EF, Kifle ZD, et al. Impact of objectively-measured sleep duration on cardiometabolic health: A systematic review of recent evidence. Frontiers in Endocrinology. 2022 Dec 19;13.
  17. Raffaele Sarnataro, Velasco CD, Monaco N, Kempf A, Gero Miesenböck. Mitochondrial origins of the pressure to sleep. Nature [Internet]. 2025 Jul 16; Available from: https://www.nature.com/articles/s41586-025-09261-y#citeas
  18. Lehrer HM, Chu LE, Hall MH, Murdock KW. Self-reported sleep efficiency and duration are associated with bioenergetic function in peripheral blood mononuclear cells (PBMCs) of adults. Mitochondrion [Internet]. 2022 Jan [cited 2026 Apr 7];62:122–7. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8724413/
  19. Hirotsu C, Tufik S, Andersen ML. Interactions between sleep, stress, and metabolism: From physiological to pathological conditions. Sleep Science [Internet]. 2015;8(3):143–52. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688585/
  20. Greenlund IM, Carter JR. Sympathetic neural responses to sleep disorders and insufficiencies. American Journal of Physiology-Heart and Circulatory Physiology. 2022 Mar 1;322(3):H337–49.
  21. Hakim F, Gozal D, Kheirandish-Gozal L. Sympathetic and Catecholaminergic Alterations in Sleep Apnea with Particular Emphasis on Children. Frontiers in Neurology. 2012;3.
  22. Nicolaides NC, Vgontzas AN, Kritikou I, Chrousos G. HPA Axis and Sleep [Internet]. Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editors. PubMed. South Dartmouth (MA): MDText.com, Inc.; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279071/
  23. Akhtar N, Salman Al-Jerdi, Kamran S, Singh R, Babu B, Abdelmoneim MS, et al. Night-Time Non-dipping Blood Pressure and Heart Rate: An Association With the Risk of Silent Small Vessel Disease in Patients Presenting With Acute Ischemic Stroke. Frontiers in Neurology. 2021 Nov 16;12.
  24. Lempiäinen PA, Ylitalo A, Heikki Huikuri, Y. Antero Kesäniemi, Ukkola OH. Non-dipping blood pressure pattern is associated with cardiovascular events in a 21-year follow-up study. Journal of Human Hypertension [Internet]. 2024 Apr 3 [cited 2025 Feb 12];38(5):444–51. Available from: https://www.nature.com/articles/s41371-024-00909-2#citeas
  25. Tang A, Yang E, Ebinger JE. Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More? Current Hypertension Reports [Internet]. 2023 Nov 13;26(1):21–30. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10796526/
  26. Dahle N, Ärnlöv J, Leppert J, Hedberg P. Nondipping blood pressure pattern predicts cardiovascular events and mortality in patients with atherosclerotic peripheral vascular disease. Vascular Medicine [Internet]. 2023 Apr 10;28(4):274–81. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10408241/
  27. Windred DP, Burns AC, Rutter MK, Lane JM, Saxena R, Frank, et al. Light Exposure at Night and Cardiovascular Disease Incidence. JAMA Network Open [Internet]. 2025 Oct;8(10):e2539031–1. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489
  28. Ansu Baidoo V, Knutson KL. Associations between circadian disruption and cardiometabolic disease risk: A review. Obesity. 2023 Feb 7;31(3):615–24.
  29. Morris CJ, Yang JN, Scheer FAJL. The impact of the circadian timing system on cardiovascular and metabolic function. Progress in Brain Research [Internet]. 2012;199:337–58. Available from: https://pubmed.ncbi.nlm.nih.gov/22877674/
  30. Mason IC, Grimaldi D, Reid KJ, Warlick CD, Malkani RG, Abbott SM, et al. Light exposure during sleep impairs cardiometabolic function. Proceedings of the National Academy of Sciences. 2022 Mar 14;119(12).
  31. Reutrakul S, Knutson KL. Consequences of Circadian Disruption on Cardiometabolic Health. Sleep Medicine Clinics. 2015 Dec;10(4):455–68.
  32. Sharpe E, Butler MP, Clark-Stone J, Soltanzadeh R, Jindal R, Hanes D, et al. A closer look at yoga nidra- early randomized sleep lab investigations. Journal of Psychosomatic Research [Internet]. 2023 Mar 1;166:111169. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0022399923000247
  33. Valērija Steinmane, Fernate A. The effect of breathing exercises on adults’ sleep quality: an intervention that works. Frontiers in Sleep. 2025 Jun 25;4.
  34. Li L, Syed N, Yoshiyuki Nishinaka, Tan Y, Kiyono K. Dynamic Sleep-Derived Heart Rate and Heart Rate Variability Features Associated with Glucose Metabolism Status: An Exploratory Feature-Selection Study Using Consumer Wearables. Sensors [Internet]. 2026 Feb 9;26(4):1118. Available from: https://www.researchgate.net/publication/400617610_Dynamic_Sleep-Derived_Heart_Rate_and_Heart_Rate_Variability_Features_Associated_with_Glucose_Metabolism_Status_An_Exploratory_Feature-Selection_Study_Using_Consumer_Wearables
  35. Panoutsopoulos A, Kallianos A, Kostopoulos K, Seretis C, Koufogiorga E, Protogerou A, et al. Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea. Medical Science Monitor. 2012;18(12):CR747–51.
  36. Savin KL, Clark TL, Perez-Ramirez P, Allen TS, Tristão Parra M, Gallo LC. The Effect of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Cardiometabolic Health Biomarkers: A Systematic Review of Randomized Controlled Trials. Behavioral Sleep Medicine. 2022 Dec 7;1–24.

Discover more from A1C Almanac

Subscribe now to keep reading and get access to the full archive.

Continue reading